Company page

Medy-tox Inc.

Medy-tox Inc. is a public company listed on the Korea stock market under the ticker 086900. The company has a market capitalization of approximately 414.3 billion KRW. Medy-tox specializes in the development and production of botulinum toxin products and other biopharmaceuticals.